Viralhemorrhagicfevers,ofwhichEbolavirus(EBOV)andLassavirus(LASV)areprototypicalexamples,area major source of human su?ering. Recent outbreaks have raised concerns about the possibility of a global outbreak.TheultimategoaloftheConsortiumforViralSystemsBiology(CViSB)istode?nenetworksofhost and viral factors that drive clinical outcomes in Ebola virus disease (EVD) and Lassa fever (LF). The responsibilities and contributions of the Technology Core fall into three main categories: data generation, technology development and standardization, and evaluation and incorporation of emerging technologies. Althoughthesecategoriesaredistinct,theyaretightlyintegrated.TheCore?sroleasdatagenerationhubfor CViSB also mandates that we continually work to develop and improve our methods and to rapidly incorporatenoveltechnologicaladvancestoensurethatweremainastate-of-the-art,productivememberof the Center. The Technology Core?s Aims are focused onthedevelopment,adaptationandstandardizationofinnovative experimental approaches in four main areas: (1) deep characterization of theadaptiveimmuneresponseto infection, (2) functional pro?ling of antiviral serum activity, (3) isolation and characterization of protective monoclonalantibodiesand(4)cost-e?cientviralgenomesequencing.InadditiontosupportingtheCenter?s ProjectsandcontributingtotheoverallsuccessofCViSB,theTechnologyCorewilltranslateits technicaland methodological advances into standardized, reproducible protocols that will bene?t other Centers and the broader infectious disease community.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI135995-04
Application #
10087875
Study Section
Special Emphasis Panel (ZAI1)
Project Start
2018-02-01
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
4
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
781613492
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Siddle, Katherine J; Eromon, Philomena; Barnes, Kayla G et al. (2018) Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018. N Engl J Med 379:1745-1753
Saphire, Erica Ollmann; Schendel, Sharon L; Fusco, Marnie L et al. (2018) Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection. Cell 174:938-952.e13
Holmes, Edward C; Rambaut, Andrew; Andersen, Kristian G (2018) Pandemics: spend on surveillance, not prediction. Nature 558:180-182
Suchard, Marc A; Lemey, Philippe; Baele, Guy et al. (2018) Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol 4:vey016
Gunn, Bronwyn M; Yu, Wen-Han; Karim, Marcus M et al. (2018) A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus. Cell Host Microbe 24:221-233.e5
Saphire, Erica Ollmann; Schendel, Sharon L; Gunn, Bronwyn M et al. (2018) Antibody-mediated protection against Ebola virus. Nat Immunol 19:1169-1178
Rambaut, Andrew; Drummond, Alexei J; Xie, Dong et al. (2018) Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst Biol 67:901-904